Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists

Bioorg Med Chem Lett. 2016 Oct 1;26(19):4684-4686. doi: 10.1016/j.bmcl.2016.08.049. Epub 2016 Aug 26.

Abstract

Members of a series of benzo[b]thiophene-2-carboxamide derivatives, possessing an N-(1-(3-bromo-4-(piperidin-4-yloxy)benzyl)piperidin-4-yl) group, were synthesized and evaluated as urotensin-II receptor antagonists. The results show that these substances have potent UT binding affinities. Observations made in a systematic SAR investigation of the effects of a variety of substituents (R(1) and R(2)) at the 5- and 6-positions in the benzo[b]thiophene-2-carboxamide moiety on UT binding affinities led to identification of the 5-cyano analog 7f as a highly potent UT antagonist with an IC50 value of 25nM. Despite having a good metabolic stability, 7f is a potent inhibitor of CYP isozyme and displays an unsuitable PK profile.

Keywords: Antagonists; Benzo[b]thiophene carboxamide; Cardiovascular disease; Urotensin-II receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Inhibitory Concentration 50
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Thiophenes / chemistry
  • Thiophenes / pharmacology*

Substances

  • Receptors, G-Protein-Coupled
  • Thiophenes
  • UTS2R protein, human